Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma

被引：66
作者：
Carr J.S. [1 ]
Zafar S.F. [2 ]
Saba N. [2 ]
Khuri F.R. [2 ]
El-Rayes B.F. [2 ]
机构：
[1] Department of Surgery, University of North Carolina, Chapel Hill, NC
[2] Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 300322
来源：
Journal of Gastrointestinal Cancer | 2013年 / 44卷 / 2期
关键词：
Esophageal adenocarcinoma; Gastric cardia adenocarcinoma; Risk factors;
D O I：
10.1007/s12029-013-9480-z
中图分类号：
学科分类号：
摘要：
Introduction In the last 30 years, the incidence of esophageal and gastric cardia adenocarcinoma has steadily increased. The increase in incidence is approximately seven-fold, which is a more substantial increase than that of several malignancies, including melanoma, breast cancer, and prostate cancer. Discussion The rising incidence has led to a steady increase in mortality from 2 to 15 deaths per 100,000 in the last three decades. The etiologic factors involved in the development of these malignancies include gastroesophageal reflux disease, Barrett's esophagus, acid-suppressivemedication use, obesity, and tobacco use. This article discusses the contribution of these etiologic risk factors to this increase in incidence. © Springer Science+Business Media New York 2013.
引用
收藏
页码：143 / 151
页数：8
相关论文
共 78 条
  • [1] El-Serag H.B., Time trends of gastroesophageal reflux disease: A systematic review, Clin Gastroenterol Hepatol, 5, pp. 17-26, (2007)
  • [2] Pohl H., Sirovich B., Welch H.G., Esophageal adenocarcinoma incidence: Are we reaching the peak?, Cancer Epidemiol Biomarkers Prev, 19, pp. 1468-1470, (2010)
  • [3] Desai H.G., Kamani P.M., Factors responsible for the increasing incidence of oesophageal adenocarcinoma, J Assoc Physicians India, 55, pp. 435-437, (2007)
  • [4] Simard E.P., Ward E.M., Siegel R., Jemal A., Cancers with increasing incidence trends in the United States: 1999 through 2008, CA Cancer J Clin, (2012)
  • [5] Moayyedi P., Talley N.J., Gastro-oesophageal reflux disease, Lancet, 367, pp. 2086-2100, (2006)
  • [6] Kim R., Weissfeld J.L., Reynolds J.C., Kuller L.H., Etiology of Barrett's metaplasia and esophageal adenocarcinoma, Cancer Epidemiol Biomarkers Prev, 6, pp. 369-377, (1997)
  • [7] Wu A.H., Wan P., Bernstein L., A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States), Cancer Causes Control, 12, pp. 721-732, (2001)
  • [8] Wu A.H., Tseng C.C., Bernstein L., Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma, Cancer, 98, pp. 940-948, (2003)
  • [9] Garcia Rodriguez L.A., Lagergren J., Lindblad M., Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: A nested case control study in the UK, Gut, 55, pp. 1538-1544, (2006)
  • [10] Farrow D.C., Vaughan T.L., Sweeney C., Et al., Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer, Cancer Causes Control, 11, pp. 231-238, (2000)
12345678